A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2
- 1 June 1982
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 26 (6), 389-400
- https://doi.org/10.1016/0049-3848(82)90311-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Familial Bleeding Tendency with Partial Platelet Thromboxane Synthetase Deficiency: Reorientation of Cyclic Endoperoxide MetabolismBritish Journal of Haematology, 1981
- THROMBOXANE SYNTHETASE INHIBITION AS ANTITHROMBOTIC STRATEGYThe Lancet, 1981
- Variables associated with radioimmunoassay of prostaglandins in plasmaProstaglandins, 1981
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981
- Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblastsCell, 1979
- The use of immobilized ligands and [125I] protein a for immunoassays of thromboxane B2, prostaglandin D2, 13,14-dihydro-prostaglandin E2, 5,6-dihydro-prostaglandin I2, 6-keto-prostaglandin F1α, 15-hydroxy-9α,11α(epoxymethano)prosta5, 13-dienoic acid and 15-hydroxy-11α,9α(epoxymethano)prosta-5,13-dienoic acidProstaglandins and Medicine, 1979
- EVIDENCE FOR DISTINCT PROSTAGLANDIN-I2 AND PROSTAGLANDIN-D2 RECEPTORS IN HUMAN-PLATELETS1979
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976